Skip to main content

Morphochemical Changes in the Brain of Rats Under the Conditions of Dopamine System Dysfunction

  • Chapter
Neurochemistry

Abstract

Drugs regulating dopamine metabolism are widely used in the treatment of patients suffering from mental diseases whose pathogenesis is supposed to be connected with dopamine system dysfunction (1,3,4,8–10,13,14). However, side effects of such interference are observed rather frequently: for example, hyperkinetic disturbances in the course of treatment of Parkinson’s disease with L-DOPA (7) or manifestations of dystonia caused by neuroleptics during treatment of schizophrenia (12).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bailey, P.E., McKenna, P.J., 1990, Triangle 29: 133–139.

    Google Scholar 

  2. Brodsky, V.Ya., 1966, Cell Trophics, Nauka, Moscow, 355 pp. (in russian).

    Google Scholar 

  3. Dubois, B., Houw, J.J., Ruberg, M., Serdaru, M., Javoy-Agid, F., Agid, Y, 1985, Rev. Neurol. 141: 184–193.

    PubMed  CAS  Google Scholar 

  4. Funk, K.F., Schmidt, J., Westermann, K.H., 1986, Biomed. Biochim. Acta. 45: 393–399.

    PubMed  CAS  Google Scholar 

  5. Gershtein, L.M., 1965, Cytologiya 76.-P.769–763 (in russian).

    CAS  Google Scholar 

  6. Katchalova, L.M., Popova, N.S., 1987, Journal Vyschey Nervnoi Deyatelnosty 37: 897–905 (in russian).

    Google Scholar 

  7. Kanerz, U., Muller, D., Hinse, P., Niemeyer, C., Lachenmayer, L., Kunze, K., 1990, New Trends Clin. Neuropharmacol. 4: 103.

    Google Scholar 

  8. Klockgether, T., Dichgans, J., 1990, J. Neurol. 237: 221–225.

    Article  PubMed  CAS  Google Scholar 

  9. Monge, A., Stocclti, F., Carta, A., De Panetis, F., Bonamartini, A., Ruggieri, S., Agnoli, A., 1990, New Trends Clin. Neuropharmacol. 4: 105.

    Google Scholar 

  10. Pacchetti, C., Bruggi, P., Martignoni, E., Grodi, L., Nappi, G., 1990, New Trends Clin. Neuropharmacol. 4: 15–26.

    Google Scholar 

  11. Popova, N.S., Katchalova, L.M., 1991, Journal Vyschey Nervnoi Deyatelnosty. 41: 9–31 (in russian).

    CAS  Google Scholar 

  12. Remington, G.J., Voineskos, G., Pollock, B., Reed, K., Coulter, K., 1990, Am. J. Psychiat. 47: 1231–1233.

    Google Scholar 

  13. Vinar, O., 1990, Eur. J. Pharmacol. 183: 107–108.

    Article  Google Scholar 

  14. Wagner, M., Kleedorfer, B., Gerstenbrand, F., Poewe, W. New Trends Clin. Neuropharmacol. 4: 95.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gershtein, L.M., Sergutina, A.V. (1997). Morphochemical Changes in the Brain of Rats Under the Conditions of Dopamine System Dysfunction. In: Teelken, A., Korf, J. (eds) Neurochemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5405-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5405-9_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7468-8

  • Online ISBN: 978-1-4615-5405-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics